SCHEMBL9758871

SCHEMBL9758871

CCCN(CCC)C1CCc2cccc(OCNC=O)c2C1

nearest known ligand 0.69

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 3/20 0.69
HTR1A P08908 3/20 0.69
HTR1B P28222 1/20 0.69
DRD2 P14416 4/20 0.59
DRD3 P35462 3/20 0.59
DRD4 P21917 1/20 0.57
HTR7 P34969 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2D6 P10635 1/20 0.56
TSHR P16473 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9758948 0.89 HTR1D (0.72) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL9759255 0.82 HTR1A (0.60) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL2218622 0.81 DRD2 (0.82) HTR1DHTR1AHTR1BDRD2DRD3
Hydrochloric Acid SCHEMBL9355015 0.80 DRD2 (0.81) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL10643830 0.80 HTR1A (0.82) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL9758461 0.80 HTR1A (0.82) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL9758475 0.79 HTR1A (0.57) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL9758885 0.79 HTR1A (0.70) HTR1DHTR1AHTR1BDRD2DRD3
Hydrochloric Acid SCHEMBL9758455 0.79 HTR1A (0.80) HTR1DHTR1AHTR1BDRD2DRD3
SCHEMBL9187345 0.78 HTR1A (0.62) HTR1DHTR1AHTR1BDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5047422-A Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract BAYER AKTIENGESELLSCHAFT (DE) 1991-09-10 US disclosed
US-4968679-A DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed
US-4873262-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT BAYER AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed